Effects of tetrathiomolybdate and penicillamine on brain hydroxyl radical and free copper levels: A microdialysis study in vivo

Biochemical and Biophysical Research Communications

Volumn 458, Issue 1, 2015, Pages 82-85

  Zhang, Ji Wei ^a   Liu, Jun Xiu ^a   Hou, Hai Man ^a,b   Chen, Ding Bang ^a   Feng, Li ^a   Wu, Chao ^a   Wei, Li Ting ^c   Li, Xun Hua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

Free copper; Hydroxyl radical d penicillamine; In vivo; Tetrathiomolybdate; Wilson disease

Indexed keywords

COPPER; HYDROXYL RADICAL; PENICILLAMINE; TETRATHIOMOLYBDIC ACID; CHELATING AGENT; MOLYBDENUM;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CHELATION THERAPY; CONTROLLED STUDY; CORPUS STRIATUM; DIALYSATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MASS SPECTROMETRY; MICRODIALYSIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; WILSON DISEASE; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; MUTANT MOUSE STRAIN;

MUS;

ANIMALS; BRAIN; CHELATING AGENTS; COPPER; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; HEPATOLENTICULAR DEGENERATION; HYDROXYL RADICAL; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICRODIALYSIS; MOLYBDENUM; PENICILLAMINE;

EID: 84922933826     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.01.071     Document Type: Article

References (26)

1. R. Purchase The treatment of Wilson's disease, a rare genetic disorder of copper metabolism Sci. Prog. 96 2013 19 32
2. G.J. Brewer, C.A. Terry, A.M. Aisen, and G.M. Hill Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy Arch. Neurol. 44 1987 490 493
3. G.J. Brewer, F. Askari, M.T. Lorincz, M. Carlson, M. Schilsky, K.J. Kluin, P. Hedera, P. Moretti, J.K. Fink, R. Tankanow, R.B. Dick, and J. Sitterly Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease Arch. Neurol. 63 2006 521 527
4. G.J. Brewer, F. Askari, R.B. Dick, J. Sitterly, J.K. Fink, M. Carlson, K.J. Kluin, and M.T. Lorincz Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine Transl. Res. 154 2009 70 77
5. K.H. Weiss, F. Thurik, D.N. Gotthardt, M. Schäfer, U. Teufel, F. Wiegand, U. Merle, D.F. Foerster, A. Maieron, R. Stauber, H. Zoller, H.H. Schmidt, U. Reuner, H. Hefter, J.M. Trocello, R.H.J. Houwen, P. Ferenci, and W. Stremmel Efficacy and safety of oral chelators in treatment of patients With Wilson Disease Clin. Gastroenterol. Hepatol. 11 2013 1028 1035 e1022
6. M. Koizumi, J. Fujii, K. Suzuki, T. Inoue, T. Inoue, J.M. Gutteridge, and N. Taniguchi A marked increase in free copper levels in the plasma and liver of LEC rats: an animal model for Wilson disease and liver cancer Free Radic. Res. 28 1998 441 450
7. J. Kalita, V. Kumar, U.K. Misra, A. Ranjan, H. Khan, and R. Konwar A study of oxidative stress, cytokines and glutamate in Wilson disease and their asymptomatic siblings J. Neuroimmunol. 274 2014 141 148
8. R. Bruha, L. Vitek, Z. Marecek, L. Pospisilova, S. Nevsimalova, P. Martasek, J. Petrtyl, P. Urbanek, A. Jiraskova, I. Malikova, M. Haluzik, and P. Ferenci Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms J. Inherit. Metab. Dis. 35 2012 541 548
9. G.A. McMillin, J.J. Travis, and J.W. Hunt Direct measurement of free copper in serum or plasma ultrafiltrate Am. J. Clin. Pathol. 131 2009 160 165
10. H.J. Stuerenburg CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease J. Neural Transm. 107 2000 321 329
11. D.B. Chen, L. Feng, X.P. Lin, W. Zhang, F.R. Li, X.L. Liang, and X.H. Li Penicillamine increases free copper and enhances oxidative stress in the brain of toxic milk mice PLoS One 7 2012 e37709
12. M. Valko, D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, and J. Telser Free radicals and antioxidants in normal physiological functions and human disease Int. J. Biochem. Cell. Biol. 39 2007 44 84
13. K. Jomova, and M. Valko Advances in metal-induced oxidative stress and human disease Toxicology 283 2011 65 87
14. A.D. Bokare, and W. Choi Review of iron-free Fenton-like systems for activating H2O2 in advanced oxidation processes J. Hazard Mater. 275 2014 121 135
15. B.S. Choi, and W. Zheng Copper transport to the brain by the blood-brain barrier and blood-CSF barrier Brain Res. 1248 2009 14 21
16. H. Rauch Toxic milk, a new mutation affecting cooper metabolism in the mouse J. Hered. 74 1983 141 144
17. S. Ono, D.J. Koropatnick, and M.G. Cherian Regional brain distribution of metallothionein, zinc and copper in toxic milk mutant and transgenic mice Toxicology 124 1997 1 10
18. K.J. Allen, N.E. Buck, D.M. Cheah, S. Gazeas, P. Bhathal, and J.F. Mercer Chronological changes in tissue copper, zinc and iron in the toxic milk mouse and effects of copper loading Biometals 19 2006 555 564
19. K.B. Franklin, and G. Paxinos Mouse brain in stereotaxic coordinates 1997
20. E.B. Yan, J.K. Unthank, M. Castillo-Melendez, S.L. Miller, S.J. Langford, and D.W. Walker Novel method for in vivo hydroxyl radical measurement by microdialysis in fetal sheep brain in utero J. Appl. Physiol. 98 2005 1985 2304 2310
21. W. Freinbichler, M.A. Colivicchi, M. Fattori, C. Ballini, K.F. Tipton, W. Linert, and C.L. Della Validation of a robust and sensitive method for detecting hydroxyl radical formation together with evoked neurotransmitter release in brain microdialysis J. Neurochem. 105 2008 738 749
22. P.J. Twomey, A. Viljoen, I.M. House, T.M. Reynolds, and A.S. Wierzbicki Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine clinical practice Clin. Chem. 51 2005 1558 1559
23. C.K. Su, Y.C. Sun, S.F. Tzeng, C.S. Yang, C.Y. Wang, and M.H. Yang In vivo monitoring of the transfer kinetics of trace elements in animal brains with hyphenated inductively coupled plasma mass spectrometry techniques Mass Spectrom. Rev. 29 2010 392 424
24. N. Marklund, F. Clausen, T. Lewander, and L. Hillered Monitoring of reactive oxygen species production after traumatic brain injury in rats with microdialysis and the 4-hydroxybenzoic acid trapping method J. Neurotrauma 18 2001 1217 1227
25. J.F. Woolley, J. Stanicka, and T.G. Cotter Recent advances in reactive oxygen species measurement in biological systems Trends Biochem. Sci. 38 2013 556 565
26. C. Themann, P. Teismann, K. Kuschinsky, and B. Ferger Comparison of two independent aromatic hydroxylation assays in combination with intracerebral microdialysis to determine hydroxyl free radicals J. Neurosci. Methods 108 2001 57 64